Actualités 104463.html
Travere therapeutics CFO sells $104,463 in stock
Thu, 30 Jan 2025 16:00:00 GMT
According to a recent SEC filing, Cline sold 5,192 shares of Travere Therapeutics at a price of $20.12 per share, totaling $104,463. This sale was conducted on February 3, 2025, as part of a ...